Eugеne P. KING, Appellant, v. R. James NICHOLSON, Secretary of Veterans Affairs, Appellee.
No. 03-1421.
United States Court of Appeals for Veterans Claims.
Argued Oct. 26, 2005. Decided Jan. 4, 2006.
19 Vet. App. 406
Before KASOLD, MOORMAN, and LANCE, Judges.
If, on remand, the Board concludes that there is no reasonably raised claim over which it has jurisdiction, the appellant is free to appeal that decision. See Mintz v. Brown, 6 Vet. App. 277, 281 (1994) (“[T]he Secretary‘s refusal to exercise jurisdiction . . . clearly presents a case or controvеrsy within the purview of the Court‘s jurisdiction.“). On remand, the appellant is free to submit additional evidence and argument and the Board must consider any such evidence or argument submitted. See Kay v. Principi, 16 Vet. App. 529, 534 (2002); Kutscherousky v. West, 12 Vet. App. 369, 372-73 (1999) (per curiam order).
III. CONCLUSION
Upon consideration of the foregoing analysis, the record on appeal, and the parties’ briefs, the Board‘s December 9, 2003, decision that denied the appellant‘s claim for reimbursement for costs incurred at а CRC facility is AFFIRMED; and the matter of whether an informal claim to reopen a previously denied claim for SMC for aid and attendance had been presented is REMANDED for further proceedings consistent with this opinion.
Debra L. Bernal, with whom Tim S. McClain, General Counsel; R. Randall Campbell, Assistant General Counsel; and Joan E. Moriarty, Deputy Assistant General Counsel were on the brief, all of Washington, D.C., for the appellee.
LANCE, Judge:
The appellant, veteran Eugene P. King, appeals through counsel an April 29, 2003, decision of the Board of Veterans’ Appeals (Board) that it was without jurisdiction to review a VA medical center (VAMC) determination that fee-basis outpatient chelation therapy was not an appropriate course of treatment for his medical condition because it is a medical matter and is thus beyond the Board‘s authority. The parties each filed briefs, and the appellant filed a reply brief. The appellant‘s brief also asserts a claim under
I. FACTS
The appellant served on active duty in the U.S. Navy from June 1957 to March
A November 4, 1996, VA “Report of Contact” indicates the appellant “called to state that he rеceived confirmation from a heavy metal blood test showing there is uranium[,] U238 [,] in his blood. He is currently having more tests done and will submit results when tests are complete.” R. at 1828. It is not clear which office of VA received this call, but the report bears a stamp from November 8, 1996, indicating that the report was received by the Washington, D.C., regional office (RO). Id. In December 1996, he requested approval for fee-basis outpatient chelation therapy; he asserted that the treatment was necessary because a blood screening conducted by a private physician, Dr. Cameron A. Gillespie, had revealed above normal levels of lead and arsenic. R. at 835-36. The letter further indicated that both results were the “by product of . . . [a]tomic [t]esting.” Id. However, the request did not include any opinion or other statement from Dr. Gillespie in support of the appellant‘s summary. Although not contained in the record, the letter indicates on its face that it included numerous attachments relating to radiation exposure experienced by those involved in military nuclear weapons testing. Id. On January 29, 1997, the Hunter Holmes McGuire VAMC in Richmond, Virginia, sent a short letter to the appellant informing him that his claim for fee-basis, outpatient chelation treatment was being denied because “it has been determined that VA [f]acilities are available for your medical treatment needs.” Supplemental (Supp.) R. at 1. The letter was signed: “Wanda Elam, Chief, Health Benefits Administration.” Id.
On February 1, 1997, the appellant responded with a letter captioned: “Notice of Disagreement [(NOD)] for denial of FEE BASIS for chelation.” R. at 843. In that letter, the appellant asked for an explanation as to “why the VAMC Richmond, Va. has never conducted the test for heavy metals.” R. at 844. The appellant also sent a letter on March 1, 1997, that, inter alia, cited Brown v. Gardner, 513 U.S. 115, 115 S. Ct. 552, 130 L. Ed. 2d 462 (1994), and asked that his “teeth be rated as service connected” based on exposure to radiation. R. at 1869.
On March 17, 1997, the VAMC sent the appellant another letter, which stated:
Dr. James K. Schmitt, the Chief of General Internal Medicine and the Chief of our Medical Service have both reviewed your request for chelation therapy. Dr. Schmitt reports that chelation is a somewhat controversial treatment in the medical community. He reports that in your case there appears to be no clinical evidence to indicate heavy metal exposure.
Since chelation therapy is a controversial medical treatment, I am not able to recommend that our Fee Basis Section approve a request for this treatment. You are currently followed by Dr. Milanese in the Medical Clinic. She will be made aware of your concerns and explore any other therapies to assist you. It is my hope that your treatment at our facility meets your every expectation, but I cannot recommеnd a therapy that my medical staff does not endorse.
Supp. R. at 3. The letter was signed by James W. Dudley, director of the Hunter Holmes McGuire VAMC. Id.
On April 8, 1997, the VAMC sent the appellant a letter indicating that his heavy metal levels would be measured during his next visit. R. at 870. There is no indica-
On appeal of the March 17, 1997, VAMC decision, the Board conceded that therе “is no dispute that the veteran is generally eligible for fee-basis outpatient treatment . . . and would be eligible for chelation therapy but for the determination that this type of therapy was not, essentially, necessary.” R. at 5. The Board observed that the appellant was seeking “authorization of private fee basis outpatient chelation therapy to remove toxic substances he alleges to hаve been exposed to. . . .” R. at 4 (emphasis added). The Board‘s discussion of the VAMC decision characterizes it as a denial based upon the grounds that the therapy “is considered a controversial therapy in the medical community, and that there was no indication of heavy metal exposure.” Id. However, the Board‘s denial of the appellant‘s claim was based exclusively on the rationale that it did not have jurisdiction because “[t]he opinion that chelation therapy is not an appropriate treatment for this veteran is exclusively a medical matter and beyond the Board‘s authority.” R. at 6 (citing
II. ANALYSIS
A. Claim for Fee-Basis Chelation Therapy
In this instance, the Board decided that it did not havе jurisdiction to review the medical appropriateness of chelation therapy treatment in the case of the appellant based on the limitations on its jurisdiction contained in
The essential question in this case is one of subject-matter jurisdiction. Our jurisdiction is limited to reviewing decisions of the Board.
In addition to our jurisdiction bеing limited to reviewing decisions of the Board, [t]his Court has adopted the jurisdictional restrictions of the case or controversy rubric under Article III of the Constitution of the United States. See Mokal v. Derwinski, 1 Vet. App. 12, 13 (1990); see also Aronson v. Brown, 7 Vet. App. 153,
Herlehy v. Principi, 15 Vet. App. 33, 35 (2001). With this in mind, we turn to what-if any-jurisdictional question has been properly presentеd to the Board and the Court.
Under
Appellate jurisdiction of determinations of the Veterans Health Administration. The Board‘s appellate jurisdiction extends to questions of eligibility for hospitalization, outpatient treatment, and nursing home and domiciliary care; for devices such as prostheses, canes, wheelchairs, bаck braces, orthopedic shoes, and similar appliances; and for other benefits administered by the Veterans Health Administration. Medical determinations, such as determinations of the need for and appropriateness of specific types of medical care and treatment for an individual, are not adjudicative matters and are beyond the Board‘s jurisdiction. Typical examplеs of these issues are whether a particular drug should be prescribed, whether a specific type of physiotherapy should be ordered, and similar judgmental treatment decisions with which an attending physician may be faced.
We begin our review of the appellant‘s argument, by noting that the Board—even when it is denying jurisdiction—is requirеd to include in its decision a written statement of the reasons or bases for its findings and conclusions on all material issues of fact and law presented on the record; that statement must be adequate to enable an appellant to understand the precise basis for the Board‘s decision, as well as to facilitate informed review in this Court. See
First, the Board‘s decision did not determine whether the appellant has a current medical condition that may be in need of treatment. As the appellant conceded at oral argument, the record does not contain a medical opinion explicitly concluding that the appellant has the condition he claims. While the appellant hаs submitted what appears to be the results of a blood test for heavy metals (R. at 1830-32), there does not appear to be any determination by the Board or the VHA as to the credibility and weight of this document. Even assuming its authenticity and
Furthermore, the Board‘s decision failed to analyze the nature of the decision bеlow. The Board simply cited
Given that the resolution of the issues raised by the appellant may invоlve very specific factual determinations regarding the nature of the evidence and the VHA procedures involved that are best for the Board to make in the first instance, the Court concludes that it is premature for the Court to address the jurisdictional issue. See Hensley v. West, 212 F.3d 1255, 1263-64 (Fed. Cir. 2000) (court of appeals may remand if it determines that lower tribunal failed to make finding of fact essential to decision); Wanless v. Principi, 18 Vet. App. 337, 337 (2004) (per curiam order); see also
On remand, the Board should decide whether the appellant has proven that he has a medical condition that may be in need of treatment. If the Board finds that the appellant has proven the existence of a medical condition, it should address the appellant‘s claim for treatment based upon clear findings as to the nature and authority of the decision being appealed. In particular, the Board should address whether the denial of the appellant‘s claim was based upon an individualized determination of need in his case or a categorical evaluation of the treatment requested.
B. Claim for Compensation under 38 U.S.C. § 1151
To the extent that the appellant claims that the Board failed to adjudicate a claim for service connection based on
The appellant argues that he raised a claim under section 1151 in his NOD by citing to Brown v. Gardner, supra, which addresses such a claim. Appellant‘s Br. at 15. Section 1151 provides compensation for disabilities caused by VA treatment.
Finally, the Court notes that the claim actually raised by the appеllant in his NOD where he made the reference to Gardner—disability caused by radiation exposure—was adjudicated on December 19, 1997, by the Roanoke, Virginia, RO and denied on the basis that no disabling condition had been shown. R. at 942, 945. However, the appellant makes no argument that that decision is before us, much less that it contains error.
C. Other arguments
The Court at this time will not address the appellant‘s other arguments. See Dunn v. West, 11 Vet. App. 462, 467 (1998) (stating that remand of appellant‘s post-traumatic stress disorder claim under one theory moots the remaining theories advanced on appeal (citing Aronson v. Brown, 7 Vet. App. 153, 155 (1994))); see also Mahl v. Principi, 15 Vet. App. 37, 38 (2001) (holding that where remand is appropriate, the Court need not “analyze and discuss all the other claimed errors that would result in a remedy no broader than a remand“). On remand, the appellant is free to submit additional evidence and argument, including the arguments raised in his briefs to this Court, in accordance with Kutscherousky v. West, 12 Vet. App. 369, 372-73 (1999) (per curiam order), and the Board must consider any such evidence or argument submitted. See Kay v. Principi, 16 Vet. App. 529, 534 (2002). The Board shall proceed expeditiously, in accordance
III. CONCLUSION
Accordingly, the appellant‘s claim for fee-basis chelation therapy is REMANDED to the Board for further proceedings consistent with this opinion and the Board‘s decision on this issue is VACATED. The appellant‘s claim under
